Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Posted inHematology Frontier

September 2 – Roundtable Discussion

Posted by By Mourabit Halima 2026.10.13Posted inHematology Frontier0 Shares
Home » September 2 – Roundtable Discussion

YouTube player
Post Views: 36

Share via:

  • Facebook
  • X (Twitter)
  • LinkedIn
  • More
Last updated on 2026.10.13
Mourabit Halima
View All Posts

Post navigation

Previous Post
Getting to the Bottom of the Debate 2.0 | Metastatic Renal Cell Carcinoma: Extrapolating Second-Line Evidence and Individualizing First-Line Dual Immunotherapy Versus Immunotherapy–TKI Combinations—A Debate Between Professors Xuewen Jiang and Hailiang Zhang Getting to the Bottom of the Debate 2.0 | Metastatic Renal Cell Carcinoma: Extrapolating Second-Line Evidence and Individualizing First-Line Dual Immunotherapy Versus Immunotherapy–TKI Combinations—A Debate Between Professors Xuewen Jiang and Hailiang Zhang
  • LinkedIn
  • Twitter
  • Mail
Related Media:
Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
Paris, France
Scroll to Top
  • Facebook
  • X (Twitter)
  • LinkedIn
  • More Networks
Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied